Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6151–6200 of 18646
the Company announced the promotion of Landen Fredrick to President and Chief Executive Officer (“CEO”) effective April 1, 2024
announcing the retirement of Alfredo (Al) Bala as the Company’s Chief Executive Officer effective April 1, 2024
the Board approved the appointment of Jonathan Cherry to serve as President and Chief Executive Officer of the Company and as a member of the Board, effective March 14, 2024.
On March 13, 2024, Laurel Sayer tendered her notice of resignation to the board of directors (the “ Board ”) of Perpetua Resources Corp. (the “ Company ”), notifying the Company of her resignation as President and Chief Executive Officer of the Company and as a member of the Board, effective March 14, 2024
On March 8, 2024, Bo Kruse, Executive Vice President, Chief Financial Officer, Secretary and Treasurer of Y-mAbs Therapeutics, Inc. (the “Company”), informed the Company of his intention to resign from such offices effective as of the date the Company appoints his successor and such successor commences employment with the Company (the “Successor Effective Date”) and to resign from employment with the Company effective July 31, 2024 (the “Effective Date”).
Joseph Otting will assume the role of President and Chief Executive Officer of the Company as of April 1, 2024.
appointed David Rosal, age 61, as its Chief Financial Officer, effective immediately.
On March 8, 2024, Timothy G. Hannon, Chief Financial Officer and principal accounting officer of WaveDancer, Inc. (the “Company”) resigned from the Company effective March 22, 2024, in order to accept another career opportunity.
On March 8, 2024, PetVivo Holdings, Inc. (the “Company”) appointed Garry Lowenthal to serve as the Company’s Chief Financial Officer.
the Board has appointed Sami Siddiqui to succeed Matthew Dunnigan as Chief Financial Officer of the Company
the Board has appointed Sami Siddiqui to succeed Matthew Dunnigan as Chief Financial Officer of the Company
The final terms of Mr. Dunnigan’s separation from the Company and termination of his employment are in the process of being finalized as of the date of this current report on Form 8-K.
the Board has appointed Sami Siddiqui to succeed Matthew Dunnigan as Chief Financial Officer of the Company
On March 12, 2024, the Board of Directors (the “Board of Directors”) of Comtech Telecommunications Corp. (“Comtech” or the “Company”) terminated Ken Peterman as President and Chief Executive Officer of the Company for cause due to conduct unrelated to Comtech’s business strategy, financial results or previously filed financial statements.
John Ratigan, age 63, who is currently the Company’s Chief Corporate Development Officer (“CCDO”), will serve as interim Chief Executive Officer, effective immediately.
On March 12, 2024, Stephen L. Faulkner, Jr. (Larry) informed Empire Petroleum Corporation (the “Company”) that he was resigning as Chief Financial Officer and Chief Accounting Officer of the Company effective on or about March 28, 2024.
On March 8, 2024, the Company accepted the resignation of Mr. Chris Wang as Chief Financial Officer of the Company effective as of March 8, 2024.
On March 12, 2024, the Board of Directors of Phoenix Motor Inc. (the “Company”) appointed Mr. J. Mark Hastings as the Company’s Chief Financial Officer, effective immediately.
Mr. Bailey has been in a transitional role and his employment formally ended effective March 12, 2024.
the Board has appointed Jeffrey N. Boyer as interim Chief Executive Officer
Kosta N. Kartsotis is stepping down from his position as Chief Executive Officer and a member of the Board of Directors
Ronald V. Coughlin, Jr., whose role as the Company’s Chief Executive Officer, Chairman and member of the Board ended effective March 12, 2024.
Edward J. Wegel was terminated as the Company’s Chief Executive Officer and Chairman of the Board of Directors, effective of February 5, 2024.
Jamie Martin has been appointed to serve as Senior Vice President and Chief Financial Officer
On March 11, 2024, the Board received and accepted the resignation of Jason T. Roos from his position as the Chief Financial Officer of the Company, effective March 31, 2024.
On March 11, 2024, Brandon Satoren was appointed by the board of directors (the “Board”) of Logan Ridge Finance Corporation (the “Company”) as the new Chief Financial Officer of the Company, effective April 1, 2024.
Effective April 1, 2024, the Board appointed Kevin A. Plank, the Company’s current Executive Chair and Brand Chief, to serve as the Company’s President and Chief Executive Officer (and principal executive officer).
Effective March 31, 2024, Brian Riley, Senior Vice President of Finance, will become GBLI’s Chief Financial Officer.
Thomas M. McGeehan, Chief Financial Officer, will retire effective March 31, 2024.
On March 12, 2024, the Company appointed Warren Wang as its Chief Executive Officer and Chairman of the Board.
On March 12, 2024, Jiang Hui resigned from his positions as Chief Executive Officer and Chairman of the Board of HUDSON ACQUISITION I CORP (the “Company”).
On March 8, 2024, the Board of Directors of Sow Good Inc. (the “Company”) appointed Claudia Goldfarb, the Company’s current Chief Executive Officer, to assume the role of Interim Chief Financial Officer until the Company appoints a successor.
that effective as of March 4, 2024 (the “Separation Date”), Carolyn J. Stone had departed the Company and was no longer serving as the Senior Vice President, Chief Financial Officer and Treasurer of the Company.
On March 8, 2024, Eric Mosser, President and the Interim Chief Executive Officer of the Company, provided written notice to the Company’s Board of his resignation, effectively immediately.
On March 7, 2024, the Board appointed Eric Morris as the Company’s Interim Chief Financial Officer, to serve in such capacity until a successor is duly appointed and approved by the Board.
On March 7, 2024, the Board appointed Nirajkumar Patel, the Company’s Chief Science and Regulatory Officer, as the Company’s Chief Executive Officer.
Ms. Puche, the Company’s outgoing Chief Financial Officer, said: “After more than 5 years at the Company, I am ready for a new phase in my life.
The board of directors (the “Board”) of Renovaro Inc. (the “Company”) appointed Simon Tarsh, age 63, as Interim Chief Financial Officer of the Company, effective March 11, 2024.
On March 12, 2024, the Company appointed Joseph Visconti as its Interim Chief Executive Officer and Dan Norton as its President.
On March 7, 2024, Weiyi Zheng resigned as Chief Executive Officer and Chairman of the Board of Battery Future Acquisition Corp. (the “Company”)
the Board of Directors of the Company appointed Fanghan Sui as Chief Executive Officer and Chairman of the Board of the Company
appointed William M. Brown chief executive officer, effective May 1, 2024
the Board of Directors (the “Board”) of Equinix, Inc. (the “Company”) approved the appointment of Adaire Fox-Martin, a current member of the Board, as its new President and Chief Executive Officer.
the Board of Directors (the “Board”) of Cencora, Inc. (the “Company”) unanimously selected Robert P. Mauch to succeed Steven H. Collis as the Company’s President and Chief Executive Officer (“CEO”), effective October 1, 2024 (the “Effective Date”), at which time he will also join the Board.
Heather Plutino, the Company’s Chief Financial Officer, has replaced Mr. Moschner as the Company’s principal accounting officer, effective March 7, 2024.
Louie Reformina, Senior Vice President and Chief Financial Officer of the Company, would be stepping down from his position in order to pursue other opportunities, effective as of March 8, 2024.
The Board of Directors of the Company (the “Board”) has appointed Andrew Flynn to serve as Senior Vice President and Chief Financial Officer of the Company, with an anticipated start date of April 1, 2024, to take Mr. Reformina’s position.
Jeffrey Liaw will become the Company’s sole Chief Executive Officer and be appointed to the Board
appointed Board member Michael De Geus as its interim President and Chief Executive Officer, and Cedrick Billequey, General Manager of the Company’s subsidiary, Biodroga Nutraceuticals, Inc. (“Biodroga”), as its Interim Chief Operating Officer
On March 6, 2024, Dr. Corinne Le Goff, Pharm.D., informed the Board of Directors (the “Board”) of Imunon, Inc. (the “Company”) of her resignation from her position as President and Chief Executive Officer of the Company and from the Board, effective as of March 15, 2024.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.